|
|
|
| Analysis on the experience of traditional Chinese medicine prevention and treatment of coronavirus disease 2019 in Zhongshan area |
| ZENG Tingting1 LAI Haibiao2 MIAO Canming2 MIAO Yingnian3 MENG Fansu4 ZENG Jianfeng5 CHEN Xingyu1 LI Leyu2 |
1.Health Services Section, Zhongshan Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangdong Province, Zhongshan 528400, China; 2.Superintendent, Zhongshan Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangdong Province, Zhongshan 528400, China; 3.Department of Emergency, Zhongshan Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangdong Province, Zhongshan 528400, China; 4.Department of Critical Care Medicine, Zhongshan Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangdong Province, Zhongshan 528400, China;
5.Urinary Surgery, Zhongshan Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangdong Province, Zhongshan 528400, China
|
|
|
|
Abstract Based on the analysis of the symptoms, tongue veins, therapeutic principle and methods and prescriptions of traditional Chinese medicine of 66 cases of coronavirus disease 2019 diagnosed in Zhongshan area of Guangdong Province, this paper concludes that coronavirus disease 2019 in Zhongshan area belongs to the category of damp warm disease in Chinese medicine. Most of the causes are the invasion of the lungs and spleen by dampness and warmness pathogen. The treatment is based on syndrome differentiation. The cure rate and the success rate of critical disease treatment in the same period can be greatly improved by using the agreement formula with Zhongshan characteristics and the addition and subtraction of Lingnan characteristic Chinese herbal medicine. At the same time, it has certain reference significance to use the characteristic prevention prescription, actively carry out the preventive treatment of disease, and further play the role of traditional Chinese medicine in the epidemic prevention and control.
|
|
|
|
|
|
[1] 国家卫生健康委办公厅，国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案（试行第七版）[EB/OL].（2020-03-03）[2020-03-15].http：//www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[2] 任培华，李振球，朱汉平，等.基于“温疫理论”探讨新型冠状病毒肺炎的中医证治规律[J].暨南大学学报：自然科学与医学版，2020，41（2）：144-150，162.
[3] 李杰，李靖，梁腾霄，等.基于中医瘟疫理论浅析新型冠状病毒肺炎病证特点及防治[J].世界中医药，2020，15（2）：172-176.
[4] 陈言.三因极一一病证方论[M].北京：人民卫生出版社，2007：29.
[5] 吴谦.医宗金鉴（上册）[M].北京：人民卫生出版社，2010：1004.
[6] 郝易.黄帝内经[M].北京：中华书局，2012：10-329.
[7] 刘耀岽，杨逸淦，柯丽萍.“温邪上受，首先犯肺，逆传心包”之辨析[J].中国中医基础医学杂志，2018，24（2）：155.
[8] 吴鞠通.温病条辨[M].北京：人民卫生出版社，1963：80.
[9] 印会河.温热夹湿论治[J].中医药研究，1987（6）：20-21.
[10] 李旗历.岭南温病辨证论治特点的研究[D].北京：北京中医药大学，2010.
[11] 萧栋，陈瑜珍，莫小路.4种广东常用清热解毒类中草药抑菌作用的研究[J].今日药学，2019，29（3）：166-169.
[12] 文达良.百年岭南常见温病诊治规律研究[D].北京：北京中医药大学，2009.
[13] 邓铁涛.岭南医学[J].新中医，1999，31（8）：8-9.
[14] 曾建峰，李乐愚，缪灿铭，等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用[J/OL].西部中医药，（2020-03-06）[2020-03-06].http：//gszy.paperopen.com/oa/darticle.aspx?type=view&id=202002494.
[15] Gan Y，Ai G，Wu J，et al. Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport [J]. J Ethnopharmacol，2020，250：112519.
[16] Jiang YQ，Liu EH. Microcos paniculata：a review on its botany，traditional uses，phytochemistry and pharmacology [J]. Chin J Nat Med，2019，17（8）：561-574.
[17] Wu Y，Zhang Z，Chen T，et al. Comparison of two Polygonum chinense varieties used in Chinese cool tea in terms of chemical profiles and antioxidant/anti-inflammatory activities [J]. Food Chem，2020，310：125840.
[18] 袁德俊，吴启端.广东土牛膝石油醚提取物的GC-MS分析[J].今日药学，2019，29（10）：673-676.
|
|
|
|
